88-LB: Kidney and Metabolic Benefits by Adding GLP-1 Agonists and/or SGLT2 Inhibitors on Metformin in Obese Type 2 Diabetes (T2DM) Patients: 24-Month Real-World Data from Both Urban and Rural Clinics

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 88-LB
Author(s):  
IOANNIS ZOUPAS ◽  
ATHANASIA PAPAZAFIROPOULOU ◽  
MARIA XENOU ◽  
DIMITRIOS LYGNOS ◽  
EVANGELOS FOUSTERIS
2020 ◽  
Author(s):  
Jersy Cardenas ◽  
Gomez Nancy Sanchez ◽  
Sierra Poyatos Roberto Miguel ◽  
Luca Bogdana Luiza ◽  
Mostoles Naiara Modroño ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 126-LB ◽  
Author(s):  
STEPHANIE HABIF ◽  
ALEXANDRA CONSTANTIN ◽  
LARS MUELLER ◽  
HARSIMRAN SINGH

2018 ◽  
Vol 21 ◽  
pp. S129
Author(s):  
F. Fiorentino ◽  
R. Ascenção ◽  
J. Costa ◽  
M. Gouveia ◽  
M. Borges

2019 ◽  
Vol 37 (8) ◽  
pp. 1291-1298
Author(s):  
D. Stoyanova ◽  
B. Stratmann ◽  
A. Schwandt ◽  
N. Heise ◽  
S. Mühldorfer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document